Effect of cysteine mutagenesis on human IgE reactivity of recombinant forms of the major rye grass pollen allergen Lol p 1

Allergology International

Volumn 52, Issue 4, 2003, Pages 183-190

  De Weerd, Nicole ^a   Bhalla, Prem L ^a   Singh, Mohan B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Allergy; Grass pollen; Lol p 1; Mutagenesis; Rye grass

Indexed keywords

CYSTEINE; EPITOPE; IMMUNOGLOBULIN E; POLLEN ALLERGEN LOL P 1; POLLEN ANTIGEN; RECOMBINANT ANTIGEN; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; DENSITOMETRY; HAY FEVER; NONHUMAN; PERENNIAL RYEGRASS; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN VARIANT; SITE DIRECTED MUTAGENESIS; SYMPTOMATOLOGY; WESTERN BLOTTING;

EID: 0346093659     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1323-8930.2003.00300.x     Document Type: Article

References (36)

1. Freidhoff LR, Ehrlich-Kautzky E, Grant JH, Meyers DA, Marsh DG. A study of the human immune response to Lolium perenne (rye) pollen and its components, Lol p 1 and Lol p II (rye I and rye II). I. Prevalence of reactivity to the allergens and correlations among skin test, IgE antibody, and IgG antibody data. J. Allergy Clin. Immunol. 1986; 78: 1190-201.
2. Ford SA, Baldo BA. A re-examination of ryegrass (Lolium perenne) pollen allergens. Int. Arch. Allergy Appl. Immunol. 1986; 81: 193-203.
3. Matthiesen F, Lowenstein H. Group V allergens in grass pollens. II. Investigation of group V allergens in pollens from 10 grasses. Clin. Exp. Allergy 1991; 21: 309-20.
4. Avjioglu A. Molecular analysis of grass pollen allergens. PhD Thesis, The University of Melbourne, Victoria, Australia. 1992.
5. Van Ree R, Driessen MN, Van Leeuwen WA, Stapel SO, Aalberse RC. Variability of crossreactivity of IgE antibodies to group I and V allergens in eight grass pollen species. Clin. Exp. Allergy 1992; 22: 611-17.
6. Avjioglu A, Singh MB, Kenrick J, Knox RB. Monoclonal antibodies to recombinant allergenic peptide to Lol p IX and the identification of corresponding epitopes in different grasses. In: Kraft D, Sehon A (eds). Molecular Biology and Immunology of Allergens. Boca Raton: CRC Press. 1993; 161-4.
7. Shcherban TY, Shi J, Durachko DM et al. Molecular cloning and sequence analysis of expansins: A highly conserved, multigene family of proteins that mediate cell wall extension in plants. Proc. Natl. Acad. Sci. USA 1995; 92: 9245-9.
8. Cosgrove DJ, Bedinger P, Durachko DM. Group I allergens of grass pollen as cell wall-loosening agents. Proc. Natl Acad. Sci. USA 1997; 94: 6559-64.
9. Grobe K, Becker WM, Schlaak M, Petersen A. Grass group I allergens (beta-expansins) are novel, papain-related proteinases. Eur. J. Biochem. 1999; 263: 33-40.
10. Grobe K, Poppelmann M, Becker WM, Petersen A. Properties of group I allergens from grass pollen and their relation to cathepsin B, a member of the C1 family of cysteine proteinases. Eur. J. Biochem. 2002; 269: 2083-92.
11. Scheiner O, Kraft D. Basic and practical aspects of recombinant allergens. Allergy 1995; 50: 384-91.
12. Nishiyama C, Fukada M, Usui Y et al. Analysis of the IgE-epitope of Der f 2, a major mite allergen, by in vitro mutagenesis. Mol. Immunol. 1995; 32: 1021-9.
13. Olsson S, van Hage-Hamsten M, Whitley P. Contribution of disulphide bonds to antigenicity of Lep d 2, the major allergen of the dust mite Lepidoglyphus destructor. Mol. Immunol. 1998; 35: 1017-23.
14. Ansari AA, Shenbagamurthi P, Marsh DG. Complete primary structure of a Lolium perenne (perennial rye grass) pollen allergen, Lol p III: Comparison with known Lol p I and II sequences. Biochemistry 1989; 28: 8665-70.
15. Esch RE, Klapper DG. Isolation and characterization of a major cross-reactive grass group I allergenic determinant. Mol. Immunol. 1989; 26: 557-61.
16. Van Ree R, van Leeuwen WA, van den Berg M, Weller HH, Aalberse RC. IgE and IgG cross-reactivity among Lol p I and Lol p II/III. Identification C-termini Lol p I, II, and III as cross-reactive structures. Allergy 1994; 49: 254-61.
17. Lamontagne P, Boutin Y, Brunet C, Boulanger J, Berton J, Hebert J. Characterization of allergenic determinants on the C-terminal region of the r-Lol p 1. Adv. Exp. Med. Biol. 1996; 409: 425-9.
18. Portnoy JM. Immunotherapy for allergic diseases. Clin. Rev. Allergy Immunol. 2001; 21: 241-59.
19. Hejjaoui A, Ferrando R, Dhivert H, Michel FB, Bousquet J. Systemic reactions occurring during immunotherapy with standardized pollen extracts. J. Allergy Clin. Immunol. 1992; 89: 925-33.
20. Smith AM, Chapman MD. Reduction in IgE binding to allergen variants generated by site-directed mutagenesis. Contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. Mol. Immunol. 1996; 33: 399-405.
21. Takai T, Yokota T, Yasue M et al. Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy. Nat. Biotechnol. 1997; 15: 754-8.
22. Griffith IJ, Smith PM, Pollock J et al. Cloning and sequencing of Lol p I, the major allergenic protein of rye-grass pollen. FEBS Lett. 1991; 279: 210-15.
23. Cohen SN, Chang ACY, Hsu L. Nonchromosomal antibiotic resistance in bacteria: Genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl Acad. Sci. USA 1972; 69: 2110-14.
24. Laemmli UK. Cleovage of structural proteins during the ossembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
25. Bradford MM. A rapid ond sensitive method for the quontitotion of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
26. Perez M, Ishioka GY, Walker LE, Chesnut RW. cDNA cloning and immunological characterization of the rye grass allergen Lol p I. J. Biol. Chem. 1990; 265: 16 210-15.
27. Bungy GA, Rodda S, Roitt I, Brostoff J. Mapping of T cell epitopes of the major fraction of rye grass using peripheral blood mononuclear cells from atopics and non-atopics. II. Isoallergen clone 5A of Lolium perenne group I (Lol p I). Eur. J. Immunol. 1994; 24: 2098-103.
28. Spiegelberg HL, Beck L, Stevenson DD, Ishioka GY. Recognition of T cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I-specific human T cell clones. J. Immunol. 1994; 152: 4706-11.
29. Schenk S, Breiteneder H, Susani M et al. T-Cell epitopes of Phl p 1, major pollen allergen of Timothy grass (Phleum pratense): Evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J. Allergy Clin. Immunol. 1995; 96: 986-96.
30. Laffer S, Valenta R, Vrtala S et al. Complementary DNA cloning of the major allergen Phl p I from Timothy grass (Phleum pratense): Recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species. J. Allergy Clin. Immunol. 1994; 94: 689-98.
31. Varney VA, Hamid QA, Gaga M et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 1993; 92: 644-51.
32. Till S, Walker S, Dickason R et al. IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin. Exp. Immunol. 1997; 110: 114-21.
33. Engel E, Richter K, Obermeyer G et al. Immunological and biological properties of Bet v 4, an novel birch pollen allergen with two EF-hand calcium-binding domains. J. Biol. Chem. 1997; 272: 28 630-7.
34. Ferreira F, Ebner C, Kramer B et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: Potential use of hypoallergenic variants for immunotherapy. FASEB J. 1998; 12: 231-42.
35. Okada T, Swoboda I, Bhalla PL, Toriyama K, Singh MB. Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy. FEBS Lett. 1998; 434: 255-60.
36. Swoboda I, de Weerd N, Bhalla PL et al. Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: Candidates for grass pollen-specific immunotherapy. Eur. J. Immunol. 2002; 32: 270-80.